Liminatus Pharma, Inc. (NASDAQ:LIMN) filed a Form 8-K with the Securities and Exchange Commission on January 26, 2026, disclosing a material event.
Liminatus Pharma, Inc.'s stock currently trades at $0.70 with a market capitalization of $23.4M. The Healthcare company's stock moved following the disclosure.